EDGAR Filing Documents for 0001387131-19-008807

Form 8-K - Current report:

SEC Accession No. 0001387131-19-008807

Filing Date

2019-11-15

Accepted

2019-11-15 17:27:21

Documents

Period of Report

2019-11-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	tnxp-8k_111419.htm	8-K	50470
2	CERTIFICATE OF DESIGNATION OF SERIES CONVERTIBLE PREFERRED STOCK	ex3-01.htm	EX-3.01	128102
3	FORM OF WARRANT	ex4-01.htm	EX-4.01	136990
4	FORM OF COMMON WARRANT	ex4-02.htm	EX-4.02	130443
5	PRESS RELEASE	ex99-01.htm	EX-99.01	20612
	Complete submission text file	0001387131-19-008807.txt		467964

Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022

Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894

Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)